Is olive leaf extract useful to treat mild hypertension?

Not Applicable

Completed

• Conditions: Hypertension; Circulatory System; Essential (primary) hypertension

• Registration Number: ISRCTN12535644
• Lead Sponsor: Institut Universitari d'Investigació en Atenció primària Jordi Gol i Gorina (IdIAP)

Brief Summary

Thesis results see attached file ISRCTN12535644 Thesis.pdf (added 04/01/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2018-07-16
• Study Completion: 2019-10-31
• Last Update Posted: 15 January 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

1. Men and women aged 25-65
2. Diagnosed with essential hypertension grade 1
3. Without allergy to the components of the leaf extract of the olive or the capsule
4. Low CV risk
5. Who don't take hypertension treatment a month before inclusion
6. Do not have a target organ lesion and/or chronic illnesses (kidney, respiratory, cardiac, liver, haematological, infectious, etc) according to the European Guide for the management of the HTA ESH ESC 2013
7. Informed consent

Exclusion Criteria

1. People with HTA grade 2 and 3
2. Grade 1 with a moderate CV risk, or high or very high according to the ESH-ESC 2013 Guidelines
3. With LOD or with subclinical vascular disease
4. With cognitive or idiomatic difficulty in fulfilling the instructions
5. Having chronic illnesses
6. Taking treatments that interfere or contraindicate the administration of the components of the olive leaf
7. Lactose intolerance
8. Pregnancy or breastfeeding

Study & Design

• Study Type: Interventional
• Study Design: Not specified